LUND, Sweden, July 8, 2025 /PRNewswire/ — Hansa Biopharma AB, “Hansa” (NASDAQ Stockholm: HNSA) today announced that Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) effective 14 ...